Green Alpha Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.8K | Sell |
29,103
-8,347
| -22% | -$28.6K | 0.1% | 103 |
|
|
2025
Q1 | $83.5K | Sell |
37,450
-385
| -1% | -$859 | 0.09% | 105 |
|
|
2024
Q4 | $111K | Sell |
37,835
-10,680
| -22% | -$31.3K | 0.09% | 141 |
|
|
2024
Q3 | $126K | Buy |
48,515
+23,806
| +96% | +$61.9K | 0.1% | 132 |
|
|
2024
Q2 | $73.1K | Sell |
24,709
-3,638
| -13% | -$10.8K | 0.06% | 135 |
|
|
2024
Q1 | $128K | Buy |
28,347
+520
| +2% | +$2.36K | 0.09% | 140 |
|
|
2023
Q4 | $159K | Sell |
27,827
-11,537
| -29% | -$65.9K | 0.11% | 148 |
|
|
2023
Q3 | $181K | Sell |
39,364
-15,051
| -28% | -$69.2K | 0.14% | 145 |
|
|
2023
Q2 | $352K | Buy |
54,415
+6,672
| +14% | +$43.1K | 0.23% | 122 |
|
|
2023
Q1 | $360K | Sell |
47,743
-950
| -2% | -$7.16K | 0.25% | 120 |
|
|
2022
Q4 | $493K | Sell |
48,693
-451
| -0.9% | -$4.57K | 0.41% | 97 |
|
|
2022
Q3 | $486K | Sell |
49,144
-447
| -0.9% | -$4.42K | 0.41% | 109 |
|
|
2022
Q2 | $528K | Buy |
49,591
+15,578
| +46% | +$166K | 0.12% | 125 |
|
|
2022
Q1 | $332K | Buy |
34,013
+5,846
| +21% | +$57.1K | 0.22% | 123 |
|
|
2021
Q4 | $403K | Buy |
28,167
+3,979
| +16% | +$56.9K | 0.27% | 115 |
|
|
2021
Q3 | $485K | Buy |
+24,188
| New | +$485K | 0.33% | 115 |
|